共 254 条
[1]
Diéras V(2004)Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer J Clin Oncol 22 4958-4965
[2]
Fumoleau P(2008)Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer J Natl Cancer Inst 100 805-814
[3]
Romieu G(2003)Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer J Clin Oncol 21 976-983
[4]
Tubiana-Hulin M(1996)Motor neuropathy due to docetaxel and paclitaxel Neurology. 47 115-118
[5]
Namer M(2003)Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 h Anticancer Drugs 14 785-792
[6]
Mauriac L(1994)Paclitaxel (taxol) induces cumulative mild neurotoxicity Eur J Cancer 30 1074-1077
[7]
Martin M(2005)Association of paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer Clin Cancer Res 11 4843-4850
[8]
Rodriguez-Lescure Ã(2013)CYP3A4*22 genotype and systemic exposure affect paclitaxel-induced neurotoxicity Clin Cancer Res 19 3316-3324
[9]
Ruiz A(2013)Germline pharmacogenetics of paclitaxel for cancer treatment Pharmacogenomics 14 1065-1084
[10]
Alba E(1994)Selective biotransformation of taxol to 6{alpha}-hydroxytaxol by human cytochrome P450 2C8 Cancer Res 54 5543-5546